Akcea Therapeutics
Cambridge, US · Founded 2015 · Delaware corporation
Founders & leadership
PO
PATRICK O'NEILExecutive
EL
ELIZABETH L. HOUGENExecutive
JG
JEFFREY GOLDBERGExecutive
PS
PAULA SOTEROPOULOSExecutive
Board
ST
STANLEY T. CROOKEBoard director
BL
B. LYNNE PARSHALLBoard director
Reported raises · per SEC filings
Form D private placements$543.2M disclosed across 1 round · 2015
▶$543.2MraisedJan 2016 · 1 investors · PharmaceuticalsRule 506(b)
▶$543.2MraisedJan 2016 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- PATRICK O'NEILExecutive Officer
- STANLEY T. CROOKEExecutive Officer, Director
- ELIZABETH L. HOUGENExecutive Officer
- JEFFREY GOLDBERGExecutive Officer
- PAULA SOTEROPOULOSExecutive Officer, Director
- B. LYNNE PARSHALLDirector
- Offering amount
- $543.2M
- Amount sold
- $543.2M
- First sale
- Dec 2015
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Akcea Therapeutics raised?
- Akcea Therapeutics has disclosed $543.2M raised across 1 round.
- Where is Akcea Therapeutics headquartered?
- Akcea Therapeutics is headquartered in Cambridge, US.